IBDEI0L2 ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10301,1,2,0)
 ;;=2^155.2
 ;;^UTILITY(U,$J,358.3,10301,1,5,0)
 ;;=5^Mal Neo Liver NOS
 ;;^UTILITY(U,$J,358.3,10301,2)
 ;;=CA of Liver^267096
 ;;^UTILITY(U,$J,358.3,10302,0)
 ;;=790.6^^61^670^1
 ;;^UTILITY(U,$J,358.3,10302,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10302,1,2,0)
 ;;=2^790.6
 ;;^UTILITY(U,$J,358.3,10302,1,5,0)
 ;;=5^Abnormal LFT's
 ;;^UTILITY(U,$J,358.3,10302,2)
 ;;=^87228
 ;;^UTILITY(U,$J,358.3,10303,0)
 ;;=571.0^^61^670^4
 ;;^UTILITY(U,$J,358.3,10303,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10303,1,2,0)
 ;;=2^571.0
 ;;^UTILITY(U,$J,358.3,10303,1,5,0)
 ;;=5^Alcoholic Fatty Liver
 ;;^UTILITY(U,$J,358.3,10303,2)
 ;;=^45182
 ;;^UTILITY(U,$J,358.3,10304,0)
 ;;=211.5^^61^670^5
 ;;^UTILITY(U,$J,358.3,10304,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10304,1,2,0)
 ;;=2^211.5
 ;;^UTILITY(U,$J,358.3,10304,1,5,0)
 ;;=5^Benign Neo Liver/BD
 ;;^UTILITY(U,$J,358.3,10304,2)
 ;;=^13300
 ;;^UTILITY(U,$J,358.3,10305,0)
 ;;=571.8^^61^670^6
 ;;^UTILITY(U,$J,358.3,10305,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10305,1,2,0)
 ;;=2^571.8
 ;;^UTILITY(U,$J,358.3,10305,1,5,0)
 ;;=5^Chr Liver Dis NEC
 ;;^UTILITY(U,$J,358.3,10305,2)
 ;;=^87404
 ;;^UTILITY(U,$J,358.3,10306,0)
 ;;=070.32^^61^670^11
 ;;^UTILITY(U,$J,358.3,10306,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10306,1,2,0)
 ;;=2^070.32
 ;;^UTILITY(U,$J,358.3,10306,1,5,0)
 ;;=5^Hepatitis B,Chr w/o Coma
 ;;^UTILITY(U,$J,358.3,10306,2)
 ;;=^303249
 ;;^UTILITY(U,$J,358.3,10307,0)
 ;;=070.54^^61^670^14
 ;;^UTILITY(U,$J,358.3,10307,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10307,1,2,0)
 ;;=2^070.54
 ;;^UTILITY(U,$J,358.3,10307,1,5,0)
 ;;=5^Hepatitis C,Chr w/o Coma
 ;;^UTILITY(U,$J,358.3,10307,2)
 ;;=^303252
 ;;^UTILITY(U,$J,358.3,10308,0)
 ;;=070.70^^61^670^15
 ;;^UTILITY(U,$J,358.3,10308,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10308,1,2,0)
 ;;=2^070.70
 ;;^UTILITY(U,$J,358.3,10308,1,5,0)
 ;;=5^Hepatitis C,Unsp w/o Coma
 ;;^UTILITY(U,$J,358.3,10308,2)
 ;;=^331436
 ;;^UTILITY(U,$J,358.3,10309,0)
 ;;=V02.62^^61^670^12
 ;;^UTILITY(U,$J,358.3,10309,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10309,1,2,0)
 ;;=2^V02.62
 ;;^UTILITY(U,$J,358.3,10309,1,5,0)
 ;;=5^Hepatitis C Carrier
 ;;^UTILITY(U,$J,358.3,10309,2)
 ;;=^317947
 ;;^UTILITY(U,$J,358.3,10310,0)
 ;;=573.3^^61^670^16
 ;;^UTILITY(U,$J,358.3,10310,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10310,1,2,0)
 ;;=2^573.3
 ;;^UTILITY(U,$J,358.3,10310,1,5,0)
 ;;=5^Hepatitis NOS
 ;;^UTILITY(U,$J,358.3,10310,2)
 ;;=^56268
 ;;^UTILITY(U,$J,358.3,10311,0)
 ;;=573.9^^61^670^19
 ;;^UTILITY(U,$J,358.3,10311,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10311,1,2,0)
 ;;=2^573.9
 ;;^UTILITY(U,$J,358.3,10311,1,5,0)
 ;;=5^Liver Disease NEC
 ;;^UTILITY(U,$J,358.3,10311,2)
 ;;=^123854
 ;;^UTILITY(U,$J,358.3,10312,0)
 ;;=782.4^^61^670^18
 ;;^UTILITY(U,$J,358.3,10312,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10312,1,2,0)
 ;;=2^782.4
 ;;^UTILITY(U,$J,358.3,10312,1,5,0)
 ;;=5^Jaundice NOS
 ;;^UTILITY(U,$J,358.3,10312,2)
 ;;=^66155
 ;;^UTILITY(U,$J,358.3,10313,0)
 ;;=577.0^^61^671^1
 ;;^UTILITY(U,$J,358.3,10313,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10313,1,2,0)
 ;;=2^577.0
 ;;^UTILITY(U,$J,358.3,10313,1,5,0)
 ;;=5^Acute Pancreatitis
 ;;^UTILITY(U,$J,358.3,10313,2)
 ;;=Acute Pancreatitis^2643
 ;;^UTILITY(U,$J,358.3,10314,0)
 ;;=577.1^^61^671^2
 ;;^UTILITY(U,$J,358.3,10314,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10314,1,2,0)
 ;;=2^577.1
 ;;^UTILITY(U,$J,358.3,10314,1,5,0)
 ;;=5^Chronic Pancreatitis
 ;;^UTILITY(U,$J,358.3,10314,2)
 ;;=Chronic Pancreatitis^259100
 ;;^UTILITY(U,$J,358.3,10315,0)
 ;;=577.2^^61^671^6
